首页> 美国卫生研究院文献>BMC Medicine >Treatment of enterohemorrhagic Escherichia coli (EHEC) infection and hemolytic uremic syndrome (HUS)
【2h】

Treatment of enterohemorrhagic Escherichia coli (EHEC) infection and hemolytic uremic syndrome (HUS)

机译:肠出血性大肠杆菌(EHEC)感染和溶血性尿毒症综合征(HUS)的治疗

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Verotoxigenic Escherichia coli (VTEC) are a specialized group of E. coli that can cause severe colonic disease and renal failure. Their pathogenicity derives from virulence factors that enable the bacteria to colonize the colon and deliver extremely powerful toxins known as verotoxins (VT) or Shiga toxins (Stx) to the systemic circulation. The recent devastating E. coli O104:H4 epidemic in Europe has shown how helpless medical professionals are in terms of offering effective therapies. By examining the sources and distribution of these bacteria, and how they cause disease, we will be in a better position to prevent and treat the inevitable future cases of sporadic disease and victims of common source outbreaks. Due to the complexity of pathogenesis, it is likely a multitargeted approach is warranted. Developments in terms of these treatments are discussed.See related article:
机译:产肠毒素的大肠埃希菌(VTEC)是一种特殊的大肠杆菌,可导致严重的结肠疾病和肾衰竭。它们的致病性来自致病性因素,致病性细菌使细菌能够在结肠中定居,并向系统循环中传递极为强大的毒素,称为Verotoxins(VT)或Shiga毒素(Stx)。在欧洲最近毁灭性的O104:H4大肠杆菌流行病表明,在提供有效疗法方面,医学专业人士是多么无助。通过检查这些细菌的来源和分布,以及它们如何引起疾病,我们将处于更好的位置,可以预防和治疗未来不可避免的散发性疾病和常见来源暴发的受害者。由于发病机理的复杂性,可能需要采取多目标方法。讨论了这些治疗方法的发展。参见相关文章:

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号